Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Journal of Clinical Pharmacy and Therapeutics|February 6, 2020
Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemiaJihyun Lee, Su Young Jung, Mi-Yeon Choi, et al.Scientific Reports|December 6, 2014
Homotypic NK cell-to-cell communication controls cytokine responsiveness of innate immune NK cellsTae-Jin Kim, Miju Kim, Hye Mi Kim, et al.Nature|July 5, 2023
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunityChuansheng Guo, Zhiyuan You, Hao Shi, et al.European Journal of Immunology|March 11, 2014
NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in miceJung Eun Lee, Seon Ah Lim, Tae-Jin Kim, et al.Nano Letters|July 13, 2012
Single step isolation and activation of primary CD3+ T lymphocytes using alcohol-dispersed electrospun magnetic nanofibersKwanghee Kim, Hyo Jin An, Seung-Hyun Jun, et al.Cancer Research|April 13, 2013
Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapySeon Ah Lim, Tae-Jin Kim, Jung Eun Lee, et al.Frontiers in Immunology|April 27, 2019
Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer PatientsSeon Ah Lim, Jungwon Kim, Seunghyun Jeon, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 21, 2025
Tumor-targeted delivery of CXCL10 by mesenchymal stromal cells potentiates adoptive T cell therapy to treat solid tumorsJeong Ho Yoon, Gyu-Bum Yeon, Hojae Lee, et al.Nature|December 13, 2019
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapyJun Wei, Lingyun Long, Wenting Zheng, et al.Nature|December 21, 2018
Metabolic heterogeneity underlies reciprocal fates of T<sub>H</sub>17 cell stemness and plasticityPeer W F Karmaus, Xiang Chen, Seon Ah Lim, et al.Pageof 3